[1] |
金沈锐, 秦旭华. 痛风及高尿酸血症动物模型的研究现状和评价[J]. 中国实验动物学报, 2005, 13(1): 55-58.
|
|
JIN S R, QIN X H. Overview of experimental animal model of gout and hyperuricemia[J]. Acta Laboratorium Animalis Scientia Sinica, 2005, 13(1): 55-58. (in Chinese with English abstract)
|
[2] |
LIU R, HAN C, WU D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. BioMed Research International, 2015, 2015: 762820.
|
[3] |
CHEN-XU M, YOKOSE C, RAI S K, et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007-2016[J]. Arthritis & Rheumatology, 2019, 71(6): 991-999.
|
[4] |
SU H Y, YANG C, LIANG D, et al. Research advances in the mechanisms of hyperuricemia-induced renal injury[J]. BioMed Research International, 2020, 2020: 5817348.
|
[5] |
ALI N, RAHMAN S, ISLAM S, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults[J]. BMC Cardiovascular Disorders, 2019, 19(1): 42.
|
[6] |
PENG T C, WANG C C, KAO T W, et al. Relationship between hyperuricemia and lipid profiles in US adults[J]. BioMed Research International, 2015, 2015: 127596.
|
[7] |
ZHANG S H, ZHANG Y C, LIN S J, et al. Hyperuricemia as a possible risk factor for abnormal lipid metabolism in the Chinese population: a cross-sectional study[J]. Annals of Palliative Medicine, 2021, 10(11): 11454-11463.
|
[8] |
YIN W, CARBALLO-JANE E, MCLAREN D G, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia[J]. Journal of Lipid Research, 2012, 53(1): 51-65.
|
[9] |
王琳, 沈嘉艳, 谢招虎, 等. 高尿酸血症动物模型研究进展[J]. 中国实验动物学报, 2023, 31(1): 112-119.
|
|
WANG L, SHEN J Y, XIE Z H, et al. Progress of hyperuricemia animal model research[J]. Acta Laboratorium Animalis Scientia Sinica, 2023, 31(1): 112-119. (in Chinese with English abstract)
|
[10] |
陈建新, 刘刚, 杨麟, 等. 5种方法制备高尿酸血症大鼠模型的实验研究[J]. 广州中医药大学学报, 2021, 38(11): 2456-2461.
|
|
CHEN J X, LIU G, YANG L, et al. Experimental study on preparation of hyperuricemia rat model by five methods[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2021, 38(11): 2456-2461. (in Chinese with English abstract)
|
[11] |
ZHU Y T, PENG X F, LING G H. An update on the animal models in hyperuricaemia research[J]. Clinical and Experimental Rheumatology, 2017, 35(5): 860-864.
|
[12] |
WEN S S, WANG D, YU H Y, et al. The time-feature of uric acid excretion in hyperuricemia mice induced by potassium oxonate and adenine[J]. International Journal of Molecular Sciences, 2020, 21(15): 5178.
|
[13] |
王冬平, 曾林, 尚世臣. 实验动物血液生理生化参考手册[M]. 北京: 科学出版社, 2011.
|
[14] |
杨桂梅, 黄胜华, 李江, 等. 腺嘌呤和氧嗪酸制作高尿酸血症大鼠模型比较[J]. 实验动物科学, 2011, 28(2): 23-26.
|
|
YANG G M, HUANG S H, LI J, et al. Compare the rat model of hyperuricemia made by adenine and oxonic acid[J]. Laboratory Animal Science, 2011, 28(2): 23-26. (in Chinese with English abstract)
|
[15] |
徐厚兰, 糜怀英. 高血压与高脂血症、高尿酸血症、高血糖的相关性分析及健康教育[J]. 护士进修杂志, 2007, 22(10): 931-932.
|
|
XU H L, MI H Y. Correlation analysis of hypertension and hyperlipidemia, hyperuricemia and hyperglycemia and health education[J]. Journal of Nurses Training, 2007, 22(10): 931-932. (in Chinese)
|
[16] |
TSUSHIMA Y, NISHIZAWA H, TOCHINO Y, et al. Uric acid secretion from adipose tissue and its increase in obesity[J]. Journal of Biological Chemistry, 2013, 288(38): 27138-27149.
|
[17] |
高倩, 李婷, 彭刘庆, 等. 中国人群中血脂成分与血尿酸间的剂量-反应关系[J]. 中华疾病控制杂志, 2023, 27(10): 1140-1145.
|
|
GAO Q, LI T, PENG L Q, et al. Dose-response association between lipid profiles and serum urate acid in Chinese adults[J]. Chinese Journal of Disease Control and Prevention, 2023, 27(10): 1140-1145. (in Chinese with English abstract)
|
[18] |
丁畅, 吴晓馗, 汤涌. 别嘌醇对合并高尿酸血症的慢性心力衰竭患者心功能的影响[J]. 黑龙江医学, 2009, 33(1): 19-20.
|
|
DING C, WU X K, TANG Y. Effects of allopurinol on cardiac function in hyperuricemic patients with chronic heart failure[J]. Heilongjiang Medical Journal, 2009, 33(1): 19-20. (in Chinese with English abstract)
|
[19] |
李媛媛, 周海燕, 吴绿英, 等. 大鼠高尿酸血症模型的建立与研究[J]. 中国实验动物学报, 2019, 27(6): 747-752.
|
|
LI Y Y, ZHOU H Y, WU L Y, et al. Establishment and study of a hyperuricemia rat model[J]. Acta Laboratorium Animalis Scientia Sinica, 2019, 27(6): 747-752. (in Chinese with English abstract)
|
[20] |
AWAD A M, SALEH M A, ABU-ELSAAD N M, et al. Erlotinib can halt adenine induced nephrotoxicity in mice through modulating ERK1/2, STAT3, p53 and apoptotic pathways[J]. Scientific Reports, 2020, 10(1): 11524.
|
[21] |
FAN S L, ZHANG P, WANG A Y, et al. Hyperuricemia and its related histopathological features on renal biopsy[J]. BMC Nephrology, 2019, 20(1): 95.
|
[22] |
WU M, MA Y W, CHEN X T, et al. Hyperuricemia causes kidney damage by promoting autophagy and NLRP3-mediated inflammation in rats with urate oxidase deficiency[J]. Disease Models & Mechanisms, 2021, 14(3): dmm048041.
|